Search Results
Search for other papers by Marianna Minnetti in
Google Scholar
PubMed
Search for other papers by Valeria Hasenmajer in
Google Scholar
PubMed
Search for other papers by Riccardo Pofi in
Google Scholar
PubMed
Search for other papers by Mary Anna Venneri in
Google Scholar
PubMed
Search for other papers by Krystallenia I Alexandraki in
Google Scholar
PubMed
Search for other papers by Andrea M Isidori in
Google Scholar
PubMed
and total motor activity were kept similar, led to excess weight gain ( Fonken et al. 2010 ). Consistent with this, CLOCK -mutant mice exhibit an attenuated diurnal feeding rhythm and develop obesity and metabolic syndrome ( Turek et al. 2005
Search for other papers by Kazunari Nohara in
Google Scholar
PubMed
Search for other papers by Suhuan Liu in
Google Scholar
PubMed
Search for other papers by Matthew S Meyers in
Google Scholar
PubMed
Search for other papers by Aurélie Waget in
Google Scholar
PubMed
Search for other papers by Mathieu Ferron in
Google Scholar
PubMed
Search for other papers by Gérard Karsenty in
Google Scholar
PubMed
Search for other papers by Rémy Burcelin in
Google Scholar
PubMed
Division of Endocrinology, Division of Endocrinology, Department of Genetics and Development, INSERM U1048, Metabolism and Molecular Medicine and Comprehensive Center on Obesity, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois 60611, USA
Search for other papers by Franck Mauvais-Jarvis in
Google Scholar
PubMed
insulin sensitivity and glucose homeostasis in NTM as in AR knockout mice. Neonatally androgenized female mice develop many of the features of the metabolic syndrome observed in women with PCOS ( Nohara et al . 2011 , 2013 ). These features include
Search for other papers by Daniel M Kelly in
Google Scholar
PubMed
Department of Human Metabolism, Robert Hague Centre for Diabetes and Endocrinology, Medical School, The University of Sheffield, Sheffield S10 2RX, UK
Search for other papers by T Hugh Jones in
Google Scholar
PubMed
Introduction There has been an alarming increase, of epidemic proportions, in both obesity and diabetes in the general population with increased cardiovascular risk associated with type 2 diabetes mellitus (T2DM) and/or metabolic syndrome (MetS
The Third Xiangya Hospital of Central South University, Changsha, Hunan, China
Search for other papers by Lei Du in
Google Scholar
PubMed
Search for other papers by Yang Wang in
Google Scholar
PubMed
Search for other papers by Cong-Rong Li in
Google Scholar
PubMed
Search for other papers by Liang-Jian Chen in
Google Scholar
PubMed
Search for other papers by Jin-Yang Cai in
Google Scholar
PubMed
Search for other papers by Zheng-Rong Xia in
Google Scholar
PubMed
Search for other papers by Wen-Tao Zeng in
Google Scholar
PubMed
Search for other papers by Zi-Bin Wang in
Google Scholar
PubMed
Search for other papers by Xi-Chen Chen in
Google Scholar
PubMed
Search for other papers by Fan Hu in
Google Scholar
PubMed
Animal Core Facility, Nanjing Medical University, Nanjing, Jiangsu, China
Search for other papers by Dong Zhang in
Google Scholar
PubMed
Search for other papers by Xiao-Wei Xing in
Google Scholar
PubMed
Search for other papers by Zhi-Xia Yang in
Google Scholar
PubMed
polycystic ovary syndrome: comparison of metabolic, hormonal, and cardiovascular risk factors . Journal of Clinical Endocrinology and Metabolism 96 1311 – 1319 . ( https://doi.org/10.1210/jc.2010-2547 ) Villarroya J Cereijo R Villarroya F 2013
Search for other papers by Simone Radavelli-Bagatini in
Google Scholar
PubMed
Search for other papers by Amy R Blair in
Google Scholar
PubMed
Search for other papers by Joseph Proietto in
Google Scholar
PubMed
Department of Medicine (Austin Health/Northern Health), Department of Physiology, Gynecological Endocrinology Unit, Heidelberg Repatriation Hospital, The University of Melbourne, 300 Waterdale Road, Heidelberg Heights, Melbourne, Victoria 3081, Australia
Search for other papers by Poli Mara Spritzer in
Google Scholar
PubMed
Search for other papers by Sofianos Andrikopoulos in
Google Scholar
PubMed
Introduction Infertility associated with oligo/anovulation, changes in ovarian structure and function, and metabolic disturbances such as obesity and insulin resistance (IR) are characteristics common to polycystic ovary syndrome (PCOS), affecting 5
Search for other papers by Thomas Nicholson in
Google Scholar
PubMed
Search for other papers by Chris Church in
Google Scholar
PubMed
Search for other papers by Kostas Tsintzas in
Google Scholar
PubMed
Search for other papers by Robert Jones in
Google Scholar
PubMed
Search for other papers by Leigh Breen in
Google Scholar
PubMed
Search for other papers by Edward T Davis in
Google Scholar
PubMed
Search for other papers by David J Baker in
Google Scholar
PubMed
Search for other papers by Simon W Jones in
Google Scholar
PubMed
reported that the prevalence of metabolic syndrome is higher in females than in males ( Beigh & Jain 2012 ), with central adiposity being a greater risk factor for metabolic diseases in females ( Li et al. 2006 , Holliday et al. 2011 ). Contrary to
Search for other papers by Laura D Brown in
Google Scholar
PubMed
metabolic syndrome and type 2 diabetes ( Barker et al . 2002 , Whincup et al . 2008 , Atlantis et al . 2009 ), and risk of cardiovascular events later in life ( Basaria & Bhasin 2012 ). Thus, suppressed development of muscle in IUGR fetuses could be a
Search for other papers by K Alexander H Iwen in
Google Scholar
PubMed
Search for other papers by Oezge Senyaman in
Google Scholar
PubMed
Search for other papers by Arne Schwartz in
Google Scholar
PubMed
Search for other papers by Maren Drenckhan in
Google Scholar
PubMed
Search for other papers by Britta Meier in
Google Scholar
PubMed
Search for other papers by Dirk Hadaschik in
Google Scholar
PubMed
Search for other papers by Johannes Klein in
Google Scholar
PubMed
Introduction Obesity and insulin resistance are at the centre of the metabolic syndrome which is a major risk factor for the development of cardiovascular disease. There is growing evidence for an implication of adipose dysfunction critically
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Search for other papers by Victor P Bilan in
Google Scholar
PubMed
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Search for other papers by Eman M Salah in
Google Scholar
PubMed
Search for other papers by Sheldon Bastacky in
Google Scholar
PubMed
Search for other papers by Huw B Jones in
Google Scholar
PubMed
Search for other papers by Rachel M Mayers in
Google Scholar
PubMed
Search for other papers by Bradley Zinker in
Google Scholar
PubMed
Search for other papers by Simon M Poucher in
Google Scholar
PubMed
Division of Pulmonary, Medicine, Pathology, Pathology, CVGI Discovery, Diabetes Drug Discovery, Allergy, and Critical Care Medicine, Vascular Medicine Institute, Departments of
Search for other papers by Stevan P Tofovic in
Google Scholar
PubMed
pathways of DN to be identified, it does not share primary features of metabolic syndrome: insulin resistance/hyperinsulinemia, obesity, and hypertension. Furthermore, STZ rats develop mild hyperlipidemia and are resistant to development of nephropathy
Department of Biosciences, Nottingham Trent University, Nottingham, UK
Search for other papers by Stuart A Morgan in
Google Scholar
PubMed
Search for other papers by Laura L Gathercole in
Google Scholar
PubMed
Search for other papers by Zaki K Hassan-Smith in
Google Scholar
PubMed
Search for other papers by Jeremy Tomlinson in
Google Scholar
PubMed
NEXUS, Discovery Way, University of Leeds, Leeds, UK
Search for other papers by Paul M Stewart in
Google Scholar
PubMed
Department of Biosciences, Nottingham Trent University, Nottingham, UK
Search for other papers by Gareth G Lavery in
Google Scholar
PubMed
improve healthspan. Interestingly, the aged phenotype shares several metabolic similarities with that of circulatory glucocorticoid (GC) excess (Cushing’s syndrome), including insulin resistance, type 2 diabetes mellitus, central obesity, hypertension